LMP-specific T-cells for Patients With Relapsed EBV-positive Lymphoma

Leiomyosarcoma

Exploring Clinical Trial Experiences of People With Leiomyosarcoma Circulating ” Cancer Cells / Macrophage ” HYbrid Cells in Patients With Sarcoma, Part 2 A Study of Unesbulin in Participants With Advanced Leiomyosarcoma (LMS) Temozolomide for Injection Combined With Epirubicin in First-line Treatment of Leiomyosarcoma Targeting ATR in Soft-tissue Sarcomas CytoreductiveSurgery & HIPEC w/Gemcitabine+Chemotherapy w/Dacarbazine in Uterine Leiomyosarcoma A Study of Rucaparib and Nivolumab in People With Leiomyosarcoma Metronomic Trabectedin, Gemcitabine, and Dacarbazine for Leiomyosarcoma S9624 Ifosfamide in Treating Patients With Meningeal Tumors A Phase 1/2 Study of CYT-0851, an Oral RAD51 Inhibitor, in B-Cell Malignancies and Advanced Solid Tumors Gemcitabine and Docetaxel With Bevacizumab in Selected Sarcoma Subtypes Cytotoxic T Cells to Treat Relapsed EBV-positive Lymphoma Basket Combination Study of Inhibitors of DNA Damage Response, Angiogenesis and Programmed Death Ligand 1 in Patients With Advanced Solid Tumors LMP-specific T-cells for Patients With Relapsed EBV-positive Lymphoma Concordance Between Gynaecologic Sonography Amd Pelvic MRI for the Pre-surgical Diagnosis of Uterine Mesenchimal Malignant Tumors A Study of PTC596 in Combination With Dacarbazine in Participants With Advanced Leiomyosarcoma (LMS) Efficacy of Gemcitabine With Pazopanib as Second Line Treatment in Patient With Metastatic or Relapsed Uterine Adjuvant Chemotherapy for High Risk Uterine Leiomyosarcoma Letrozole Versus Observation in Patients With Newly Diagnosed Uterine Leiomyosarcoma Letrozole in Women With Advanced Estrogen/Progesterone Receptor Positive Uterine Leiomyosarcoma Development of a Predictive Model for Early Differential Diagnosis of Uterine Leiomyomas and Leiomyosarcomas Trabectedin, Doxorubicin and Olaratumab in Patients With Metastatic or Recurrent Leiomyosarcoma